Trial site
South Texas Accelerated Research Therapeutics
- 5running trials
- 9closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer9 trials
- Colorectal cancer7 trials
- Liver and biliary tract cancer7 trials
- Pancreatic cancer7 trials
- Head and neck cancer6 trials
- Bladder cancer5 trials
- Gastric and oesophageal cancer5 trials
- Ovarian cancer4 trials
- Endometrial cancer3 trials
- Prostate cancer3 trials
- Cervical cancer2 trials
- Kidney cancer2 trials
- and 6 more
- Phase
- Phase 18 trials
- Phase 1/26 trials
- Status
- Completed5 trials
- Terminated4 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Amgen2 trials
- Incyte Corporation2 trials
- Bolt Biotherapeutics, Inc.1 trial
- Bristol-Myers Squibb1 trial
- Coherus Oncology, Inc.1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Active, not recruiting
A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
Active, not recruiting
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer2 recruiting
- Lung cancer2 recruiting
- Pancreatic cancer2 recruiting
- Sarcoma2 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Melanoma1 recruiting
- Mesothelioma1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Terminated
Completed
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
Terminated
Completed
Completed
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Terminated
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Terminated
A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies
Site data: ClinicalTrials.govUpdated 14 Nov 2026